HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Is there structural change on MRI in gluteal tendinopathy after treatment? Single outcome measure extension of an RCT.

AbstractBACKGROUND:
The etiology of tendinopathy remains controversial and it is unknown whether degenerative structural changes in tendinopathies are reversible.
HYPOTHESIS:
There will be no structural change on magnetic resonance imaging (MRI) taken > 2-years after treatment for gluteal tendinopathy.
STUDY DESIGN:
Extension of a single site, double-blind, prospective randomized-controlled trial to analyze the additional outcome measure; MRI changes.
METHODS:
University of Melbourne ethics approval number: 1852900, trial registration: ACTRN12613000677707. Participants with gluteal tendinopathy who had previously received a leukocyte-rich platelet-rich plasma injection (LR-PRP) or a corticosteroid injection (CSI) had a post treatment MRI between at least 2-years and up to 7 years following trial completion. A blinded, senior musculoskeletal radiologist graded all de-identified MRI scans using the Melbourne Hip Score (MHIP). The primary outcome measure was the change in overall pre- and post-treatment score.
RESULTS:
Participants (n = 20) underwent MRI at mean time of 4.15 (SD 1.11; range 2-7) years after their initial treatment. There was no change in the overall mean MHIP score for the CSI group (Pre 4.3 (SD 2.3) Post 4.3 (SD 1.1), p = 1.00). Although there was an improvement in the LR-PRP group mean MHIP score (Pre 5.3 (SD 3.0) Post 4.77 (SD 2.5), p = 0.56) it was not statistically significant. However, in the LR-PRP intervention group, five out of nine of participants' MHIP score improved, with four of these improving by 2-4 points.
CONCLUSION:
The hypothesis that there would be no improvement in MHIP scores following treatment of gluteal tendinopathy was supported. Findings of improvement in the LR-PRP group at 4 years would support further studies powered to look for structural improvement. These findings suggest that structural change following treatment for tendinopathy may be possible supporting the inclusion of MRI as a core outcome for future studies.
CLINICAL RELEVANCE:
The study suggests that degenerative structural changes in tendons may be reversible.
AuthorsGeorgia Carney, Jane Fitzpatrick
JournalBMC medical imaging (BMC Med Imaging) Vol. 23 Issue 1 Pg. 179 (11 08 2023) ISSN: 1471-2342 [Electronic] England
PMID37940869 (Publication Type: Randomized Controlled Trial, Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2023. The Author(s).
Chemical References
  • toliprolol
  • Adrenal Cortex Hormones
Topics
  • Humans
  • Prospective Studies
  • Tendinopathy (diagnostic imaging, therapy)
  • Magnetic Resonance Imaging
  • Adrenal Cortex Hormones
  • Outcome Assessment, Health Care

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: